Choice of prosthetic heart valves:update for the next generation
David S. Bach, MD, FACC*,*
* Department of Medicine, Division of Cardiology, University of Michigan, Ann Arbor, Michigan, USA

View larger version (30K):
[in a new window]
|
Figure 1 Freedom from all valve-related complications for tissue and mechanical prostheses (from Veterans Affairs trial [3], reprinted with permission from the American College of Cardiology Foundation). Morbidity was composed predominantly of late structural failure among patients with a bioprosthesis and cumulative occurrence of major hemorrhage among patients with a mechanical prosthesis. Freedom from all valve-related complications for tissue and mechanical prostheses was indistinguishable at 12 years AVR = aortic valve replacement; MVR = mitral valve replacement.
|
|
|